Literature DB >> 16199320

Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions.

Nathalie Crokart1, Bénédicte F Jordan, Christine Baudelet, Reginald Ansiaux, Pierre Sonveaux, Vincent Grégoire, Nelson Beghein, Julie DeWever, Caroline Bouzin, Olivier Feron, Bernard Gallez.   

Abstract

PURPOSE: To characterize changes in the tumor microenvironment early after irradiation and determine the factors responsible for early reoxygenation. METHODS AND MATERIALS: Fibrosarcoma type II (FSaII) and hepatocarcinoma transplantable liver tumor tumor oxygenation were determined using electron paramagnetic resonance oximetry and a fiberoptic device. Perfusion was assessed by laser Doppler, dynamic contrast-enhanced MRI, and dye penetration. Oxygen consumption was determined by electron paramagnetic resonance. The interstitial fluid pressure was evaluated by the wick-in-needle technique.
RESULTS: An increase in oxygen partial pressure was observed 3-4 h after irradiation. This increase resulted from a decrease in global oxygen consumption and an increase in oxygen delivery. The increase in oxygen delivery was due to radiation-induced acute inflammation (that was partially inhibited by the antiinflammatory agent diclofenac) and to a decrease in interstitial fluid pressure. The endothelial nitric oxide synthase pathway, identified as a contributing factor at 24 h after irradiation, did not play a role in the early stage after irradiation. We also observed that splitting a treatment of 18 Gy into two fractions separated by 4 h (time of maximal reoxygenation) had a greater effect on tumor regrowth delay than when applied as a single dose.
CONCLUSION: Although the cell cycle redistribution effect is important for treatment protocols using multiple daily radiation fractions, the results of this work emphasize that the oxygen effect must be also considered to optimize the treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199320     DOI: 10.1016/j.ijrobp.2005.02.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  42 in total

1.  Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.

Authors:  Susan L Dalrymple; Robyn E Becker; Haoming Zhou; Theodore L DeWeese; John T Isaacs
Journal:  Prostate       Date:  2011-08-11       Impact factor: 4.104

Review 2.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

3.  The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.

Authors:  David L Schwartz; Garth Powis; Arun Thitai-Kumar; Yi He; James Bankson; Ryan Williams; Robert Lemos; Junghwan Oh; Andrei Volgin; Suren Soghomonyan; Ryuichi Nishii; Mian Alauddin; Uday Mukhopadhay; Zhenghong Peng; William Bornmann; Juri Gelovani
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

4.  Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.

Authors:  Nadeem Khan; Sriram Mupparaju; Shahryar K Hekmatyar; Huagang Hou; Jean P Lariviere; Eugene Demidenko; David J Gladstone; Risto A Kauppinen; Harold M Swartz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-31       Impact factor: 7.038

5.  Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.

Authors:  Huagang Hou; Zrinka Abramovic; Jean P Lariviere; Marjeta Sentjurc; Harold Swartz; Nadeem Khan
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

Review 6.  Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.

Authors:  Megan Morisada; Michael Chamberlin; Clint Allen
Journal:  Head Neck       Date:  2018-02-20       Impact factor: 3.147

7.  PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

Authors:  M Busk; L S Mortensen; M Nordsmark; J Overgaard; S Jakobsen; K V Hansen; J Theil; J F Kallehauge; F P D'Andrea; T Steiniche; M R Horsman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-18       Impact factor: 9.236

8.  In vivo imaging of changes in tumor oxygenation during growth and after treatment.

Authors:  Anna Bratasz; Ramasamy P Pandian; Yuanmu Deng; Sergey Petryakov; John C Grecula; Nilendu Gupta; Periannan Kuppusamy
Journal:  Magn Reson Med       Date:  2007-05       Impact factor: 4.668

9.  Tissue oxygenation in a murine SCC VII tumor after X-ray irradiation as determined by EPR spectroscopy.

Authors:  Hirotada Fujii; Koh-Ichi Sakata; Yoshihiro Katsumata; Rikiya Sato; Makoto Kinouchi; Masanori Someya; Shin-Ichiro Masunaga; Masato Hareyama; Harold M Swartz; Hiroshi Hirata
Journal:  Radiother Oncol       Date:  2008-02-20       Impact factor: 6.280

10.  Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.

Authors:  David Campos; Wenny Peeters; Kwangok Nickel; Brian Burkel; Johan Bussink; Randall J Kimple; Albert van der Kogel; Kevin W Eliceiri; Michael W Kissick
Journal:  Radiat Res       Date:  2016-04-29       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.